SEOUL, South Korea, July 14, 2020 /PRNewswire/ — VUNO Inc., South Korean artificial intelligence (AI) developer announced that it will attend the European Congress of Radiology 2020 (ECR 2020) to be held from July 15 to July 19, 2020 to showcase the power of its flagship AI radiology solutions that have recently received the CE mark. As part of its ambitious plan to go global, VUNO is set to seize this opportunity to further expand its networks with sales prospects and business partners from all around the world. VUNO’s booth at RSNA 2019 ECR, one of the leading events in the field of radiology, will be joined by industry experts, medical & healthcare professionals, modality manufacturers and solutions developers, etc. In the light of the COVID 19 epidemic, the congress organizers have decided to opt for an online-only event. With about 2,100 leading industry representatives onboard, the exhibition of ECR 2020 can be accessed from 08:00 a.m. July 15 to 21, until 11:55 p.m. CEST. Free registration & participation is available on the ECR 2020 Virtual Exhibition website. (https://ecr2020.expo-ip.com/). VUNO’s exhibition at the event will include VUNO Med®–LungCT AI™ that detects, locates, and quantifies pulmonary lung nodules on CT images, VUNO Med®-Chest X-Ray™ that assists in the chest X-ray readings of common thoracic abnormalities on chest radiographs. VUNO Med®-DeepBrain™ is a diagnostic supporting tool for degenerative brain diseases through brain parcellation & quantification on brain MR images. On top of the three solutions to be showcased at this event, VUNO has two other solutions that have gained CE certifications recently – VUNO Med®-BoneAge™ and VUNO Med® – Fundus AI. All these five products are now available to be marketed in countries where CE marking is acceptable. VUNO Med® solutions are designed to be agnostic to any devices and any environments offering seamless integration with any PACS and/or EMR systems. They are offered via cloud servers allowing users to analyze images anytime, anywhere with access to the Internet. They are also available through on-premise installations as well. VUNO has the highest number of clients with more than 120 medical institutions in Korea alone. With its huge successes under its belt rooted in the proven effectiveness and safety through clinical trials and practices, the company is embarking on a new endeavor to proclaim its technical prowess in overseas markets now by signing partnerships with global healthcare giants like M3, a SONY subsidiary and Japan’s largest data platform company. For more detailed information on VUNO, visit https://www.vuno.co/. Related Links :https://www.vuno.co
Donate To The Indian Sun
Dear Reader,The Indian Sun is an independent organisation committed to community journalism. We have, through the years, been able to reach a wide audience especially with the growth of social media, where we also have a strong presence. With platforms such as YouTube videos, we have been able to engage in different forms of storytelling. However, the past few years, like many media organisations around the world, it has not been an easy path. We have a greater challenge. We believe community journalism is very important for a multicultural country like Australia. We’re not able to do everything, but we aim for some of the most interesting stories and journalism of quality. We call upon readers like you to support us and make any contribution. Do make a DONATION NOW so we can continue with the volume and quality journalism that we are able to practice.
Thank you for your support.
Best wishes,
Team The Indian Sun
